APPLICATION
ANDA202650
TYPE
ANDA
ORIGINAL APPROVAL
2013-03-04
LATEST ACTION
2020-10-19
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ZOLEDRONIC ACIDPrescription
ZOLEDRONIC ACID EQ 4MG BASE/5ML · INJECTABLE · INTRAVENOUS
Approval history
2020-10-19Labeling · Supplement 10 · standardAP
2016-11-30Labeling · Supplement 7 · standardAP
2015-10-20Labeling · Supplement 6 · standardAP
2015-03-12Labeling · Supplement 5 · standardAP
2015-03-12Labeling · Supplement 2 · standardAP
2013-03-04UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.